1. Home
  2. MIST vs SRBK Comparison

MIST vs SRBK Comparison

Compare MIST & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • SRBK
  • Stock Information
  • Founded
  • MIST 2003
  • SRBK 1887
  • Country
  • MIST Canada
  • SRBK United States
  • Employees
  • MIST N/A
  • SRBK N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • SRBK
  • Sector
  • MIST Health Care
  • SRBK
  • Exchange
  • MIST Nasdaq
  • SRBK Nasdaq
  • Market Cap
  • MIST 81.5M
  • SRBK 96.1M
  • IPO Year
  • MIST N/A
  • SRBK N/A
  • Fundamental
  • Price
  • MIST $1.43
  • SRBK $10.81
  • Analyst Decision
  • MIST Strong Buy
  • SRBK
  • Analyst Count
  • MIST 3
  • SRBK 0
  • Target Price
  • MIST $13.00
  • SRBK N/A
  • AVG Volume (30 Days)
  • MIST 177.8K
  • SRBK 20.6K
  • Earning Date
  • MIST 11-11-2024
  • SRBK 01-01-0001
  • Dividend Yield
  • MIST N/A
  • SRBK N/A
  • EPS Growth
  • MIST N/A
  • SRBK N/A
  • EPS
  • MIST N/A
  • SRBK N/A
  • Revenue
  • MIST N/A
  • SRBK $22,814,000.00
  • Revenue This Year
  • MIST N/A
  • SRBK N/A
  • Revenue Next Year
  • MIST N/A
  • SRBK N/A
  • P/E Ratio
  • MIST N/A
  • SRBK N/A
  • Revenue Growth
  • MIST N/A
  • SRBK 52.54
  • 52 Week Low
  • MIST $1.12
  • SRBK $8.01
  • 52 Week High
  • MIST $3.52
  • SRBK $11.24
  • Technical
  • Relative Strength Index (RSI)
  • MIST 42.50
  • SRBK 51.76
  • Support Level
  • MIST $1.41
  • SRBK $10.97
  • Resistance Level
  • MIST $1.53
  • SRBK $11.09
  • Average True Range (ATR)
  • MIST 0.07
  • SRBK 0.06
  • MACD
  • MIST -0.01
  • SRBK -0.05
  • Stochastic Oscillator
  • MIST 26.96
  • SRBK 5.50

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About SRBK SR Bancorp Inc. Common stock

SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.

Share on Social Networks: